UnknownNot Applicable

Treatment of Postsphincterotomy Bleeding With a Novel Self-assembling Peptide Hemostatic Gel.

Czechia80 participantsStarted 2022-08-01

Plain-language summary

The aim of this observational study is to evaluate safety and efficacy of a novel self-assembling peptide hemostatic gel in reduction of bleeding after endoscopic sphincterotomy during ERCP (endoscopic retrograde cholangiopancreatography )

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * . All patients indicated for ERCP with papilosphincterotomy or precut. * Participant is willing and able to give informed consent for participation in the study Exclusion Criteria: * Known allergy to a novel hemostatic agent * Gravidity * Inability to sign informed consent

What they're measuring

Number of bleeding episodes after ERCP sfincterothomy or precut

Timeframe: One month

Trial details

NCT IDNCT05886127

SponsorGeneral University Hospital, Prague

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-31

Contact for this trial

Petr Hrabak, MD

224962580 petr.hrabak@vfn.cz

View on ClinicalTrials.gov More Biliary Obstruction trials